Antitumor activity of thaliblastine (NSC-68075) in experimental ovarian tumor cell lines sensitive and resistant to cisplatin
- 29 February 1992
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 62 (2) , 173-177
- https://doi.org/10.1016/0304-3835(92)90189-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell lineZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell lineZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- Resistance ot cisplatin and analogues: mechanisms and potential clinical implicationsCancer Chemotherapy and Pharmacology, 1988
- ThaliblastineDrugs of the Future, 1988
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Interaction of 99mTc-labeled liposomes with walker tumour cells in vitro. Liposome-mediated introduction of thaliblastine into resistant walker tumour cellsGeneral Pharmacology: The Vascular System, 1982
- Incorporation of the antitumor alkaloid thaliblastine in liposomes enhances its cytotoxic activity in vitroCellular and Molecular Life Sciences, 1982
- Biochemical effects of d-tetrandrine and thalicarpineBiochemical Pharmacology, 1976
- Thalictrum Alkaloids IJournal of Pharmaceutical Sciences, 1963